What is 21 CFR Part 11?
In our digital era, FDA-regulated industries are supposed to be confident that their e-records and signatures are no less reliable than paper ones. It is here that 21 CFR Part 11 is used. It is an essential regulation developed by the U.S Food and Drug Administration (FDA) that establishes the specifications in and under which electronic records and electronic signatures are trusted trustworthy, dependable, and practically indistinguishable to paper records.
What is a Clinical Trial Application (CTA) and Why it Matters
Clinical trials play a vital role in the making of new medicines and treatments that lead to a healthier patient. But no new drug can be tested on human beings until the researchers in Canada get the official authority. This authorization is through a Clinical Trial Application (CTA) by Health Canada.
What is a Biologics License Application (BLA) and Why is it Important in Drug Approval?
Have you ever thought how innovative biologic medicines like vaccines, gene therapies, or monoclonal antibodies find their way into the lab, and into the hands of patients? One key component of this process is the Biologics License Application (BLA), a formal submission to the U.S. Food and Drug Administration (FDA) that guarantees the adherence to rigorously high safety, effectiveness and quality standards of these complex medicines before they are approved to market.
What Is Drug Master File (DMF) Submission?
Drug Master File (DMF) submission is a classified document that is submitted to the U.S. Food and Drug Administration (FDA) and entails detailed data regarding the manufacturing, processing, packaging or storage of the components employed in the pharmaceutical drug products.
ICSR Management: Ensuring Patient Safety Through Effective Case Handling
In pharmacovigilance, adverse drug reaction (ADR) report gathering and analysis is critical to the overall protection of the health of the population. Another essential part of this initiative is the Individual Case Safety Report (ICSR) a harmonic framework of storing and reporting the suspected adverse reactions of medicinal products.